Boothbay Fund Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $524,511 - $812,882	-36,782 Reduced 54.88%	30,236 $467,000
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $271,324 - $347,879	-18,271 Reduced 21.42%	67,018 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $1.06 Million - $1.73 Million	85,289 New	85,289 $1.58 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $148,137 - $239,564	-21,563 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $105,644 - $509,423	13,720 Added 174.93%	21,563 $211,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $21,855 - $30,685	826 Added 11.77%	7,843 $267,000
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $229,666 - $336,465	7,017 New	7,017 $257,000
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $628,875 - $899,915	-30,454 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $341,570 - $646,978	17,902 Added 142.62%	30,454 $639,000
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $421,370 - $528,439	12,552 New	12,552 $486,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.